"J&J Accuses Big Health Insurer of Helping Drain Its Drug Copay Funds; Pharmaceutical Company Claims Cigna Units Worked With SaveOn and Caused It to Pay More Than $100 Million in Copay Assistance Than It Would Have Otherwise" - WSJ
"J&J Accuses Big Health Insurer of Helping Drain Its Drug Copay Funds; Pharmaceutical Company Claims Cigna Units Worked With SaveOn and Caused It to Pay More Than $100 Million in Copay Assistance Than It Would Have Otherwise" - WSJ
"強生指控大型健康保險公司幫助耗盡其藥品共付基金；藥品公司聲稱Cigna單位與SaveOn合作，導致其支付的共付援助超過10000萬美元，遠超原本應支付的金額" - 華爾街日報
Johnson & Johnson has sued divisions of health insurer Cigna, accusing them of working with a drug-benefit middleman to drain J&J financial-assistance funds earmarked for patients taking some of its pricier drugs.
強生公司已起訴健康保險公司Cigna的幾個部門，指控他們與藥品福利中介合作，侵佔了強生爲使用某些昂貴藥物的患者預留的財務援助資金。
The move by J&J widens litigation the healthcare giant initiated in 2022 against a middleman, SaveOnSP LLC, and is a new flare-up of long-running tension over drug prices among manufacturers, insurers, pharmacy-benefit managers and other middlemen in recent years.
強生公司的這一舉動擴大了其在2022年對中介SaveOnSP LLC提起的訴訟，並且是近年來製造商、保險公司、藥品福利經理和其他中介之間在藥品價格問題上長期緊張關係的新一次升級。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。